Balchem Co. (NASDAQ:BCPC) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans lessened its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 5.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,478 shares of the basic materials company’s stock after selling 1,438 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Balchem were worth $4,484,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the business. Chesapeake Capital Corp IL lifted its stake in shares of Balchem by 27.9% in the third quarter. Chesapeake Capital Corp IL now owns 3,307 shares of the basic materials company’s stock worth $579,000 after buying an additional 721 shares in the last quarter. Natixis Advisors LLC lifted its stake in Balchem by 2.1% in the 3rd quarter. Natixis Advisors LLC now owns 21,797 shares of the basic materials company’s stock worth $3,836,000 after purchasing an additional 453 shares in the last quarter. Zions Bancorporation N.A. boosted its holdings in shares of Balchem by 17.2% during the 3rd quarter. Zions Bancorporation N.A. now owns 10,976 shares of the basic materials company’s stock worth $1,932,000 after purchasing an additional 1,612 shares during the last quarter. Empower Advisory Group LLC grew its position in shares of Balchem by 1.1% in the third quarter. Empower Advisory Group LLC now owns 113,427 shares of the basic materials company’s stock valued at $19,963,000 after purchasing an additional 1,201 shares in the last quarter. Finally, Geneva Capital Management LLC increased its holdings in shares of Balchem by 1.7% in the third quarter. Geneva Capital Management LLC now owns 779,869 shares of the basic materials company’s stock valued at $137,257,000 after purchasing an additional 12,750 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Stock Up 1.2 %

Shares of NASDAQ BCPC opened at $182.44 on Monday. The company has a market capitalization of $5.93 billion, a P/E ratio of 49.04, a P/E/G ratio of 5.39 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The company has a 50 day simple moving average of $173.84 and a 200-day simple moving average of $166.71. Balchem Co. has a 1 year low of $120.81 and a 1 year high of $186.03.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on BCPC shares. HC Wainwright boosted their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.